ARROWHEAD PHARMACEUTICALS IN's ticker is ARWR and the CUSIP is 04280A100. A total of 288 filers reported holding ARROWHEAD PHARMACEUTICALS IN in Q1 2021. The put-call ratio across all filers is 0.47 and the average weighting 0.3%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $460,498 | -28.6% | 17,138 | -5.2% | 0.00% | 0.0% |
| Q2 2023 | $644,983 | +76.6% | 18,087 | +25.8% | 0.00% | 0.0% |
| Q1 2023 | $365,125 | -41.4% | 14,375 | -6.4% | 0.00% | 0.0% |
| Q4 2022 | $622,758 | +29.2% | 15,354 | +5.2% | 0.00% | 0.0% |
| Q3 2022 | $482,000 | -1.0% | 14,593 | +5.4% | 0.00% | 0.0% |
| Q2 2022 | $487,000 | -16.2% | 13,843 | +9.6% | 0.00% | 0.0% |
| Q1 2022 | $581,000 | -30.3% | 12,636 | +0.5% | 0.00% | 0.0% |
| Q4 2021 | $834,000 | +0.2% | 12,578 | -5.6% | 0.00% | 0.0% |
| Q3 2021 | $832,000 | -20.1% | 13,323 | +6.0% | 0.00% | -50.0% |
| Q2 2021 | $1,041,000 | +68.7% | 12,573 | +35.2% | 0.00% | +100.0% |
| Q1 2021 | $617,000 | -7.2% | 9,301 | +7.3% | 0.00% | 0.0% |
| Q4 2020 | $665,000 | +84.7% | 8,669 | +3.8% | 0.00% | 0.0% |
| Q3 2020 | $360,000 | -0.3% | 8,353 | 0.0% | 0.00% | 0.0% |
| Q2 2020 | $361,000 | +17.6% | 8,353 | -21.7% | 0.00% | 0.0% |
| Q1 2020 | $307,000 | -61.5% | 10,671 | -15.1% | 0.00% | -50.0% |
| Q4 2019 | $798,000 | +117.4% | 12,576 | -3.5% | 0.00% | +100.0% |
| Q3 2019 | $367,000 | +2.5% | 13,037 | -3.4% | 0.00% | 0.0% |
| Q2 2019 | $358,000 | +80.8% | 13,502 | +25.4% | 0.00% | 0.0% |
| Q1 2019 | $198,000 | -23.8% | 10,767 | -48.5% | 0.00% | 0.0% |
| Q4 2018 | $260,000 | +3614.3% | 20,927 | +375.4% | 0.00% | – |
| Q2 2017 | $7,000 | +75.0% | 4,402 | +83.3% | 0.00% | – |
| Q1 2017 | $4,000 | -60.0% | 2,402 | -62.5% | 0.00% | – |
| Q4 2016 | $10,000 | -79.2% | 6,402 | -1.5% | 0.00% | – |
| Q3 2016 | $48,000 | +269.2% | 6,502 | +159.9% | 0.00% | – |
| Q2 2016 | $13,000 | – | 2,502 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| WESTERN FINANCIAL Corp | 820,346 | $62,945,000 | 41.38% |
| Johnson & Johnson Innovation - JJDC, Inc. | 3,260,869 | $250,206,000 | 32.27% |
| Aquilo Capital Management, LLC | 365,926 | $28,078,000 | 5.84% |
| L1 Capital Pty Ltd | 298,687 | $23,127,000 | 4.32% |
| First Light Asset Management, LLC | 704,449 | $54,052,000 | 4.00% |
| ACUTA CAPITAL PARTNERS, LLC | 139,000 | $10,665,000 | 2.90% |
| Evolutionary Tree Capital Management, LLC | 48,265 | $3,703,000 | 2.82% |
| Parkman Healthcare Partners LLC | 127,171 | $9,758,000 | 2.50% |
| Capital Impact Advisors, LLC | 88,183 | $6,766,000 | 1.66% |
| Tri Locum Partners LP | 56,003 | $4,297,000 | 1.56% |